Naveiro-Rilo J C, García García S, Flores-Zurutuza L, Carazo Fernández L, Domínguez Fernández C, Palomo García J L
Gerencia de Atención Primaria, León, España.
Servicio de Neumología, Hospital de León, León, España.
Rev Calid Asist. 2017 Sep-Oct;32(5):262-268. doi: 10.1016/j.cali.2017.05.001. Epub 2017 Aug 31.
To evaluate the differences in COPD patients below the lower limit of normal (LLN) of the fixed ratio FEV1/FVC < 0.70 and those above this limit.
Cross-sectional study. COPD patients between 40 and 85 years old included in primary care clinical record database were randomly selected. Baseline and postbronchodilator spirometries were performed. Two groups of patients were established: FEV1/FVC<0.70 and ≤LIN (group1) and FEV/FVC<0.70 and >LIN (group 2). Sociodemographic, clinical, pulmonary obstruction, quality of life and attendance to health services variables were measured. The results of both groups were compared.
22.3% of the subjects were misdiagnosed FEV1/FVC < 0,70. Patients in group 2 (FEV1/FVC<0.70 y > LLN) are diagnosed at an older age, they have a lower exposure to tobacco and better pulmonary function (FEV1: 74.9% vs 54.6%). 35.5% of those patients belong to stage i of GOLD, vs 8.5%, this patients have an increased comorbidity. Patients in group 1 have more COPD exacerbations, worse quality of life, a higher BODEx index 2,3 (1.8) vs 1.1 (1.5); 55.1% of those patients were high risk patients (GoldC or Gold D). Diagnose before being 56 years old, an increased exposure to tobacco, the FEV>50%, and a lower comorbidity are associated with a greater chance of suffering COPD with LLN criteria.
We obtain two groups of patients with differentiated clinical characteristics if we use LLN. Subjects with FEV1/FVC<0.7 and >LLN have less obstruction, less severity and more comorbidity, suggesting the possibility of overdiagnosis or misdiagnosis. On the other hand, younger age at the time of diagnosis, higher tobacco consumption and more severe obstruction are related with FEV1/FVC >0.70 and<LLN (group 1).
评估慢性阻塞性肺疾病(COPD)患者中,固定比值第一秒用力呼气容积(FEV1)/用力肺活量(FVC)低于正常下限(LLN)(FEV1/FVC<0.70)者与高于该下限者之间的差异。
横断面研究。从基层医疗临床记录数据库中随机选取年龄在40至85岁之间的COPD患者。进行基线和支气管扩张剂使用后的肺功能测定。将患者分为两组:FEV1/FVC<0.70且≤LLN(第1组)和FEV/FVC<0.70且>LLN(第2组)。测量社会人口统计学、临床、肺阻塞、生活质量及医疗服务就诊情况等变量。比较两组结果。
22.3%的受试者FEV1/FVC<0.70被误诊。第2组(FEV1/FVC<0.70且>LLN)患者诊断时年龄较大,烟草暴露较少,肺功能较好(FEV1:74.9%对54.6%)。这些患者中35.5%属于慢性阻塞性肺疾病全球倡议(GOLD)1期,而第1组为8.5%,该组患者合并症更多。第1组患者COPD急性加重更频繁,生活质量更差,BODEx指数更高[2.3(1.8)对1.1(1.5)];这些患者中55.1%为高风险患者(GOLD C或GOLD D)。56岁之前被诊断、烟草暴露增加、FEV>50%以及合并症较少与按照LLN标准患COPD的可能性更大相关。
若采用LLN标准,我们得到了两组具有不同临床特征的患者。FEV1/FVC<0.7且>LLN的受试者阻塞程度较轻、病情较轻但合并症较多,提示可能存在过度诊断或误诊。另一方面,诊断时年龄较小、烟草消费量较高以及阻塞更严重与FEV1/FVC>0.70且<LLN(第1组)相关。